Root Financial Partners’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
FFM
APM
OCA
Root Financial Partners's DNTH Position: Q2 2026 in Review
Root Financial Partners sold out of Dianthus Therapeutics (DNTH) in Q2 2026, closing a stake of 3 shares — an estimated $252 sold.
Root Financial Partners first reported a position in DNTH in Q1 2026 and held it in 1 quarter. The position peaked at $252 in Q1 2026. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.
- Root Financial Partners reported no remaining Dianthus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Root Financial Partners sold 3 Dianthus Therapeutics shares in Q2 2026, an estimated $252.
- Root Financial Partners first reported a position in Dianthus Therapeutics in Q1 2026 and held it in 1 quarter.
- Root Financial Partners's Dianthus Therapeutics position peaked at $252 in Q1 2026.
- 269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.
Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.